Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IRAK1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
IRAK1 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, expressed in, implicated in. Associated with Als, Cancer, Epilepsy. Connected to 43 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | IRAK1 |
| Protein Family | IL-1 receptor-associated kinases |
| Protein Type | Serine/Threonine Kinase |
| Function | IRAK1 is a serine/threonine kinase recruited to activated TLR/IL-1R complexes via MyD88. |
| Molecular Weight | 77 kDa |
| Amino Acids | 712 aa |
| Pathways | NF-κB, MAPK pathway, MAPK, NF-κB pathway |
| UniProt ID | [P51617](https://www.uniprot.org/uniprot/P51617) |
| GeneCards | IRAK1 |
| Human Protein Atlas | IRAK1 |
| N-terminal Death Domain (DD) | Mediates interactions with MyD88 and other adaptor proteins |
| ProST domain | Proline-rich region involved in protein-protein interactions |
| Kinase Domain (KD) | Catalytic domain with serine/threonine kinase activity |
| C-terminal domain | Regulatory region controlling kinase activity |
| Phosphorylation | Autophosphorylation at multiple serine/threonine residues (Thr387, Ser376) activates the kinase |
| Associated Diseases | neurodegeneration |
| Interactions | AKT, ASC, ASK1, ATF3, ATG5, CCR2 |
| KG Connections | 75 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
IRAK1["IRAK1"]
Epilepsy{"Epilepsy"}
IRAK1 -->|"expressed in"| Epilepsy
Ms{"Ms"}
IRAK1 -->|"expressed in"| Ms
Als{"Als"}
IRAK1 -->|"expressed in"| Als
IKBKG["IKBKG"]
IRAK1 -->|"expressed in"| IKBKG
TLR2["TLR2"]
IRAK1 -->|"expressed in"| TLR2
TLR1["TLR1"]
IRAK1 -->|"expressed in"| TLR1
HMGB1["HMGB1"]
IRAK1 -->|"expressed in"| HMGB1
IKBKB["IKBKB"]
IRAK1 -->|"expressed in"| IKBKB
IL8["IL8"]
IRAK1 -->|"expressed in"| IL8
Nf__b(["Nf-Kappab"])
IRAK1 -->|"expressed in"| Nf__b
Complement(["Complement"])
IRAK1 -->|"expressed in"| Complement
neurodegeneration["neurodegeneration"]
IRAK1 -->|"implicated in"| neurodegeneration
TLR4["TLR4"]
TLR4 -->|"expressed in"| IRAK1
IL1B["IL1B"]
IL1B -->|"expressed in"| IRAK1
CYTOKINES["CYTOKINES"]
CYTOKINES -->|"expressed in"| IRAK1
TLR3["TLR3"]
TLR3 -->|"expressed in"| IRAK1
PROINFLAMMATORY_CYTOKINES["PROINFLAMMATORY CYTOKINES"]
PROINFLAMMATORY_CYTOKINES -->|"expressed in"| IRAK1
NF__B["NF-KappaB"]
NF__B -->|"expressed in"| IRAK1
RAGE["RAGE"]
RAGE -->|"expressed in"| IRAK1
IRAK2["IRAK2"]
IRAK2 -->|"expressed in"| IRAK1
IL10["IL10"]
IL10 -->|"expressed in"| IRAK1
TRAF6["TRAF6"]
TRAF6 -->|"activates"| IRAK1
style IRAK1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Ms | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Epilepsy | expressed_in | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| TLR2 | expressed_in | gene | 0.60 |
| TLR1 | expressed_in | gene | 0.60 |
| HMGB1 | expressed_in | gene | 0.60 |
| IKBKB | expressed_in | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| MAPK1 | therapeutic_target | gene | 0.60 |
| XIAP | therapeutic_target | gene | 0.60 |
| TRAF6 | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| ISG15 | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| LAMP2 | activates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| MLKL | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| NMDAR | activates | gene | 0.60 |
| NF-ΚB | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| BCL-2 | therapeutic_target | gene | 0.60 |
| MICRORNAS | therapeutic_target | gene | 0.60 |
| Pi3K/Akt | therapeutic_target | pathway | 0.60 |
| Apoptosis | therapeutic_target | pathway | 0.60 |
| Microrna | therapeutic_target | pathway | 0.60 |
| Mapk | therapeutic_target | pathway | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| Nf-Κb | therapeutic_target | pathway | 0.60 |
| IKBKG | expressed_in | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| NLR | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| apoptosis pathway | participates_in | pathway | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| blood-brain barrier | participates_in | pathway | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| necroptosis | participates_in | pathway | 0.60 |
| IL8 | expressed_in | gene | 0.60 |
| Complement | expressed_in | pathway | 0.60 |
| Il-1 | activates | protein | 0.60 |
| IL1R1 | regulates | gene | 0.60 |
| Nf-Κb | expressed_in | pathway | 0.60 |
| Immune Response | regulates | pathway | 0.60 |
| RAGE | activates | gene | 0.55 |
| NF-kB signaling | participates_in | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AKT | activates | gene | 0.60 |
| ASC | activates | gene | 0.60 |
| ATF3 | activates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| CCR2 | activates | gene | 0.60 |
| CHOP | activates | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| CYTOKINES | regulates | gene | 0.60 |
| ASK1 | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| IFN | activates | gene | 0.60 |
| TLR4 | expressed_in | gene | 0.60 |
| IL1B | expressed_in | gene | 0.60 |
| TLR3 | expressed_in | gene | 0.60 |
| RAGE | expressed_in | gene | 0.60 |
| IRAK2 | expressed_in | gene | 0.60 |
| IL10 | expressed_in | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| TOLLIP | activates | gene | 0.60 |
| TRAF6 | activates | gene | 0.60 |
| CYTOKINES | expressed_in | gene | 0.60 |
| PROINFLAMMATORY CYTOKINES | expressed_in | gene | 0.60 |
| NF-ΚB | expressed_in | gene | 0.60 |
| MIRNAS | therapeutic_target | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| KRAS | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IRAK1 in their description or question text
No additional research found